MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 234 filers reported holding MYRIAD GENETICS INC in Q1 2016. The put-call ratio across all filers is 2.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,732 | +14.8% | 70,798 | 0.0% | 0.00% | +33.3% |
Q1 2024 | $1,509 | +11.4% | 70,798 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $1,355 | +19.3% | 70,798 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $1,136 | -34.7% | 70,798 | -5.6% | 0.00% | -25.0% |
Q2 2023 | $1,739 | -4.6% | 75,037 | -4.3% | 0.00% | 0.0% |
Q1 2023 | $1,822 | +53.8% | 78,441 | -4.0% | 0.00% | +33.3% |
Q4 2022 | $1,185 | -99.9% | 81,692 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $1,559,000 | +10.7% | 81,692 | +5.4% | 0.00% | +33.3% |
Q2 2022 | $1,408,000 | -26.6% | 77,492 | +1.8% | 0.00% | -25.0% |
Q1 2022 | $1,918,000 | +0.6% | 76,116 | +10.2% | 0.00% | 0.0% |
Q4 2021 | $1,907,000 | -13.5% | 69,098 | +1.2% | 0.00% | -20.0% |
Q3 2021 | $2,205,000 | +5.6% | 68,298 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $2,089,000 | +0.4% | 68,298 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $2,080,000 | +63.8% | 68,298 | +6.4% | 0.00% | +33.3% |
Q4 2020 | $1,270,000 | +51.7% | 64,198 | 0.0% | 0.00% | +50.0% |
Q3 2020 | $837,000 | +10.9% | 64,198 | -3.6% | 0.00% | 0.0% |
Q2 2020 | $755,000 | -24.0% | 66,598 | -4.0% | 0.00% | -33.3% |
Q1 2020 | $993,000 | -50.6% | 69,398 | -6.1% | 0.00% | -40.0% |
Q4 2019 | $2,012,000 | +32.9% | 73,898 | +39.7% | 0.01% | +25.0% |
Q3 2019 | $1,514,000 | +7.5% | 52,898 | +4.3% | 0.00% | 0.0% |
Q2 2019 | $1,408,000 | -16.5% | 50,698 | -0.2% | 0.00% | 0.0% |
Q1 2019 | $1,686,000 | +14.9% | 50,798 | +0.6% | 0.00% | 0.0% |
Q4 2018 | $1,468,000 | -34.3% | 50,491 | +3.9% | 0.00% | -20.0% |
Q3 2018 | $2,236,000 | +23.3% | 48,616 | +0.2% | 0.01% | +25.0% |
Q2 2018 | $1,813,000 | +28.3% | 48,516 | +1.4% | 0.00% | +33.3% |
Q1 2018 | $1,413,000 | -13.8% | 47,831 | +0.2% | 0.00% | -25.0% |
Q4 2017 | $1,639,000 | +26.6% | 47,731 | +33.3% | 0.00% | +33.3% |
Q3 2017 | $1,295,000 | +82.9% | 35,800 | +30.7% | 0.00% | +50.0% |
Q2 2017 | $708,000 | +40.8% | 27,400 | +4.6% | 0.00% | +100.0% |
Q1 2017 | $503,000 | +322.7% | 26,200 | +351.7% | 0.00% | – |
Q3 2016 | $119,000 | -35.3% | 5,800 | -3.3% | 0.00% | – |
Q2 2016 | $184,000 | -18.2% | 6,000 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $225,000 | – | 6,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |